Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - June 10, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company"), a leader in developing eco-friendly antimicrobial compounds, is ...
Transferring a biologic candidate from the research and development phase to commercial production usually requires increasing the working volume of the upstream bioprocess. During scale-up, process ...
Scale-down modeling accelerates the development of downstream biopharma manufacturing processes. Biopharmaceutical manufacturing involves a series of complex unit operations linked together to provide ...
The bioproduction of biologics such as plasmids and enzymes is crucial for the development of biopharmaceuticals like cutting-edge gene therapies. However, scaling microbial fermentation from the lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback